Tag: functional claiming
-
Wyeth v. AstraZeneca: Federal Circuit Invalidates Cancer-Treatment Claims for Failure to Enable Patient Dosing
The Federal Circuit’s decision in Wyeth LLC v. AstraZeneca Pharmaceuticals LP, Case No. 2024-2325 (Fed. Cir. July 9, 2026), affirms that a patent claiming daily administration of a therapeutically effective drug dosage to a patient must teach more than laboratory activity and broad projected dosage ranges. The specification must provide sufficient guidance for a skilled…
-
TrackTime v. Amazon.com: Federal Circuit Requires Contextual § 112(f) Analysis for Software Claim Terms
The Federal Circuit’s decision in TrackTime, LLC v. Amazon.com Services LLC, Case No. 2024-1102 (Fed. Cir. July 2, 2026), clarifies how courts must determine whether software claim language invokes means-plus-function treatment under 35 U.S.C. § 112(f), particularly when a claim recites “executable program code” configured to perform specified operations. The court vacated a judgment that…
-
US Patent No. 7,679,637 v. Google: Federal Circuit Rejects Functional Claims Under Section 101
On January 22, 2026, the Federal Circuit affirmed the dismissal of a patent infringement complaint against Google at the pleading stage, holding that the asserted claims of U.S. Patent No. 7,679,637 are patent-ineligible under 35 U.S.C. § 101. The decision reinforces a familiar theme in modern eligibility jurisprudence: claims drafted at a high level of…